IMP761 was well tolerated in healthy volunteers when given at single increasing doses, with no safety concerns, according to ...
– Rapid, deep, and durable reductions in high-sensitivity C-reactive protein (hs-CRP) through Day 90 achieved across all pacibekitug arms with high statistical significance as compared to placebo (p<0 ...
Two large phase 3 trials found that oral semaglutide 14 mg did not slow cognitive or functional decline over 104 weeks in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results